OD, Pre-Test- Applying Cervical Cancer Screening Guidelines to Clinical Practice

1. On-Demand Webinar - Pre Test

Question Title

Please take a minute to complete this pre-session survey to help ARHP assess the impact of its educational programs. Completing this survey will provide ARHP with an invaluable tool for understanding how health professionals use educational offerings and how ARHP activities might be improved to serve you better.

Question Title

* 1. Today's Date

Enter today's date

Date

Question Title

* 2. Profession (choose the one best response):

Health Professional Educator

Nurse Midwife

Nurse Practitioner

Patient Educator/Counselor

Pharmacist

Physician (MD/DO)

Physician Assistant

Registered Nurse

Resident

Student

Other (please specify)

Question Title

* 3. Specialty (choose the one best response)

Obstetrics/Gynecology

Family medicine

Internal medicine

Pediatrics

Other (please specify)

Question Title

* 4. Major professional activity (choose the one best response)

Direct patient care activities

Administrative activities

Medical education

Medical research

Other (please specify)

Question Title

* 5. Do you interact with patients?

Yes

Question Title

* 6. Which of the following statements about HPV infection is true?

Only a small fraction of infections is cleared by the immune system.

The average episode of infection lasts 4-6 years.

HPV type 16 is more likely to be associated with persistent infection than other types.

Transient and persistent infections are equally likely to progress to invasive cervical cancer.

Question Title

* 7. Regarding extended intervals for cervical cancer screening, which of the following is true?

Annual cervical cancer screening results in more invasive testing with little difference in the number of cancer cases or mortality compared with less frequent testing.

Cervical cancer screening should be an integral component of the Well-Woman visit every year for average risk women.

Cervical cancer screening has NOT been associated with potential harms.

None of the above.

Question Title

* 8. Which of the following is true about the management of women age 30 or older with Pap negative/HPV positive results?

Genotyping is recommended for use only in women less than age 25.

Either reflex or immediate genotyping for HPV 16 and 18 is an option for triage in this population of women.

Genotyping is unnecessary; women in this population should proceed immediately to colposcopy, regardless of the genotype result.

None of the above is true.

Question Title

Question Title

* 1. Today's Date

Question Title

* 2. Profession (choose the one best response):

Question Title

* 3. Specialty (choose the one best response)

Question Title

* 4. Major professional activity (choose the one best response)

Question Title

* 5. Do you interact with patients?

Question Title

* 6. Which of the following statements about HPV infection is true?

Question Title

* 7. Regarding extended intervals for cervical cancer screening, which of the following is true?

Question Title

* 8. Which of the following is true about the management of women age 30 or older with Pap negative/HPV positive results?

Question Title

* 9. As a result of participating in this activity, I hope to be better able to: